Literature DB >> 3502707

Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.

M A Bender, T D Palmer, R E Gelinas, A D Miller.   

Abstract

Replication-competent retroviruses can be modified to carry nonviral genes. Such gene transfer vectors help define regions of the retroviral genome that are required in cis for retroviral replication. Moloney murine leukemia virus has been used extensively in vector construction, and all of the internal protein-encoding regions can be removed and replaced with other genes while still allowing production of virions containing and transmitting the altered retroviral genome. However, inclusion of a portion of the gag region from Moloney murine leukemia virus markedly increases the titer of virus derived from these vectors. We determined that this effect was due to more efficient packaging of the vector RNA into particles and did not depend on protein synthesis from the gag region. We conclude that the retrovirus packaging signal extends into the gag region. We have found that retroviral vectors containing the complete packaging signal allow more efficient gene transfer into a variety of cell types. In addition, these results may help explain why many oncogenic retroviruses have retained gag sequences and often express transforming proteins that are gag-onc hybrids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502707      PMCID: PMC254146          DOI: 10.1128/JVI.61.5.1639-1646.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Effect of internal viral sequences on the utility of retroviral vectors.

Authors:  D Armentano; S F Yu; P W Kantoff; T von Ruden; W F Anderson; E Gilboa
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

2.  A new dominant hybrid selective marker for higher eukaryotic cells.

Authors:  F Colbère-Garapin; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  J Mol Biol       Date:  1981-07-25       Impact factor: 5.469

3.  Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1.

Authors:  C M Wei; M Gibson; P G Spear; E M Scolnick
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent.

Authors:  P Schwartzberg; J Colicelli; S P Goff
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

5.  Sequence relationship of glycosylated and unglycosylated gag polyproteins of Moloney murine leukemia virus.

Authors:  S A Edwards; H Fan
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

6.  Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus.

Authors:  P R Shank; M Linial
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

7.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms.

Authors:  S A Edwards; H Fan
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

10.  A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT.

Authors:  A D Miller; D J Jolly; T Friedmann; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  152 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration.

Authors:  W P Lynch; A H Sharpe; E Y Snyder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Authors:  M Hildinger; K L Abel; W Ostertag; C Baum
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  The 17 nucleotides downstream from the env gene stop codon are important for murine leukemia virus packaging.

Authors:  S S Yu; J M Kim; S Kim
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons.

Authors:  M Sena-Esteves; Y Saeki; S M Camp; E A Chiocca; X O Breakefield
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Novel retroviral vectors to facilitate expression screens in mammalian cells.

Authors:  Eugene Y Koh; Tong Chen; George Q Daley
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

7.  High-frequency intracellular transposition of a defective mammalian provirus detected by an in situ colorimetric assay.

Authors:  T Tchenio; T Heidmann
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes.

Authors:  Y Takahara; K Hamada; D E Housman
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.

Authors:  F Clavel; J M Orenstein
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

10.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.